Jan-Frederik Keustermans’ practice focuses on corporate transactions, artificial intelligence, intellectual property, technology, and data privacy.

Jan-Frederik represents buyers and sellers in domestic and cross-border mergers and acquisitions and complex carve-outs and business separations. He also extensively advises corporate clients on Belgian and European IP, AI, data privacy (GDPR), corporate, securities, and commercial law questions, including in relation to licensing agreements, commercial contracts, corporate governance, disclosure, and insider trading.

Jan-Frederik also has experience in civil and criminal litigation and in selected regulated sectors, including conducting internal investigations in the banking sector.

Jan-Frederik joined the firm in 2013 as a stagiaire and returned to the firm as an associate in 2015. From 2018 to 2019, he was a resident in the New York office.

Read More

Notable Experiences

  • Alimentation Couche Tard in the proposed €3.1 billion acquisition of TotalEnergies’ retail network in Germany, the Netherlands, Belgium, and Luxembourg.

  • Collibra in the redomiciliation of its parent entity from Belgium to the Netherlands.

  • A large secondaries investor as lead investor in a GP-led secondary transaction with a major credit sponsor for the acquisition of credit assets from a variety of Ares managed funds.

  • Western Digital in the sale of its ActiveScale business to Quantum Corporation.

  • Ontex in the contemplated sale of its Brazilian activities.

  • Solvay in its contemplated separation into two independent publicly listed companies.

  • Westlake Chemical in its acquisition of Hexion’s Epoxy business for approximately $1.2 billion.

  • Finnish company Valmet in its acquisition of North American-based GL&V.

  • Umicore in its €142.4 million sale of its Umicore Zinc Chemicals business to OpenGate Capital.

  • State Grid International Development in connection with its proposed €850 million subscription of a 14% stake in Eandis Assets.

  • General Motors in the €1.3 billion sale of its Opel/Vauxhall subsidiary and in the €0.9 billion sale of its GM Financial’s European operations to PSA Group.

  • Agilent Technologies in its $250 million acquisition of ACEA Biosciences.

  • CVC Capital Partners (Fund V) in its exit sale of Continental Foods to GBfoods, a division of Spanish food group Agrolimen.

See More

Selected Activities

Graduate Editor, Journal of International Law and Politics, New York University School of Law

Editor in Chief, Jura Falconis, University of Leuven

Publications